Acute Myeloid Leukemia in Children
Open Access
- 13 December 2018
- book chapter
- Published by Springer Nature
- p. 523-530
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabineBlood Advances, 2018
- Prognostic significance of flow‐cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP‐AML 2002/01 study protocolBritish Journal of Haematology, 2017
- Ipilimumab for Patients with Relapse after Allogeneic TransplantationNew England Journal of Medicine, 2016
- Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimensBlood, 2014
- Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBIBlood, 2013
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study GroupJournal of Clinical Oncology, 2013
- The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approachNature Reviews Clinical Oncology, 2012
- Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission RateJournal of Clinical Oncology, 2011
- Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemiaHaematologica, 2009
- Impact of Disease Risk on Efficacy of Matched Related Bone Marrow Transplantation for Pediatric Acute Myeloid Leukemia: The Children's Oncology GroupJournal of Clinical Oncology, 2008